NewAmsterdam Pharma Company NV - NAMS - stock price prediction, stock price target, analyst ratings from 13 analysts

NewAmsterdam Pharma Company NV has a share price target of US$ 41, revenue growth forecast of -28.9%, and profit growth estimate of 34.0% for FY25, based on top 13 analyst calls.